CAS RN: 2060024-61-3
Pyridine, 5-bromo-4-methyl-2-(1-methylethyl)-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260208
100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2060024-61-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2060024-61-3 / 5-bromo-4-methyl-2-propan-2-ylpyridine
Standard CAS: 2060024-61-3
Multi CAS: No
Basic Information
copy
CAS
2060024-61-3 copy
Multi CAS
No copy
Molecular Formula
C9H12BrN copy
Molecular Weight
214.100000 copy
Exact Mass
213.015310 copy
SMILES
CC1=CC(=NC=C1Br)C(C)C copy
InChI
InChI=1S/C9H12BrN/c1-6(2)9-4-7(3)8(10)5-11-9/h4-6H,1-3H3 copy
InChIKey
SJXJOMHSZXTXIV-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.44 copy
Rotatable bonds
1 copy
H-bond acceptors
1 copy
Molar refractivity
50.76 copy
TPSA
12.89 copy
LogP / Solubility
WLOGP
3.28 copy
MLOGP
2.88 copy
XLogP3
3.1 copy
Consensus LogP
3.09 copy
Log S (ESOL)
-3.57 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.68 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.89 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.7 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy